The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies. Since 1992, MDMA has been the voice for medical technology innovation, playing a proactive role in helping to shape policies that impact the ecosystem. This is accomplished by working with key Members of Congress, senior staff at FDA, CMS and other agencies, and through the grassroots support of our members.
Numerous provisions of the Affordable Care Act (ACA) continue to be implemented impacting med tech innovators and all stakeholders in the health care delivery system. MDMA is at the forefront ensuring that the voice of our members and the medical technology community is heard.
From leading efforts to repeal the medical device tax, to ensuring that the regulatory environment is more predictable and reasonable and that there is a fair and adequate reimbursement system in place for medical technology, MDMA is the leading advocate on the major issues affecting our industry.
Working Groups
MDMA’s working groups address the many challenges facing innovative medical device companies and drive MDMA’s advocacy and educational efforts. Each working group meets monthly via conference call and receives additional email updates and breaking news on a consistent basis.
Current MDMA Working Groups include:
FDA
Coverage & Reimbursement
Compliance
Communications
Cybersecurity
Healthcare Reform Implementation
Pain Management
International
Patent Reform
MDMA's Mission
MDMA's mission is to promote public health and improve patient care through the advocacy of innovative, research-driven medical device technology.
MDMA Advocacy
MDMA plays a proactive role in helping to shape policy that impacts the medical device innovator. To achieve these goals, MDMA represents its members' collective interests before the United States Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal agencies that develop or implement policies that affect the medical device industry. MDMA encourages its members to actively engage in the advocacy process through MDMA Working Group participation and grassroots mobilization.
Website：MDMA
The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies. Since 1992, MDMA has been the voice for medical technology innovation, playing a proactive role in helping to shape policies that impact the ecosystem. This is accomplished by working with key Members of Congress, senior staff at FDA, CMS and other agencies, and through the grassroots support of our members.
Numerous provisions of the Affordable Care Act (ACA) continue to be implemented impacting med tech innovators and all stakeholders in the health care delivery system. MDMA is at the forefront ensuring that the voice of our members and the medical technology community is heard.
From leading efforts to repeal the medical device tax, to ensuring that the regulatory environment is more predictable and reasonable and that there is a fair and adequate reimbursement system in place for medical technology, MDMA is the leading advocate on the major issues affecting our industry.
Working Groups
MDMA’s working groups address the many challenges facing innovative medical device companies and drive MDMA’s advocacy and educational efforts. Each working group meets monthly via conference call and receives additional email updates and breaking news on a consistent basis.
Current MDMA Working Groups include:
FDA
Coverage & Reimbursement
Compliance
Communications
Cybersecurity
Healthcare Reform Implementation
Pain Management
International
Patent Reform
MDMA's Mission
MDMA's mission is to promote public health and improve patient care through the advocacy of innovative, research-driven medical device technology.
MDMA Advocacy
MDMA plays a proactive role in helping to shape policy that impacts the medical device innovator. To achieve these goals, MDMA represents its members' collective interests before the United States Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal agencies that develop or implement policies that affect the medical device industry. MDMA encourages its members to actively engage in the advocacy process through MDMA Working Group participation and grassroots mobilization.
Website：MDMA